Expression of nm23-M1 Gene in Mouse Myelomonocytic Leukemia

doi:10.3969/j.issn.1674-5817.2014.01.008

Abstract

Abstract: Objective To investigate the expression level of nm23-M1 gene in mouse myelomonocytic leukemia. Methods The mice were inoculated intravenously with myelomonocytic leukemia cells of WEHI-3 cells, and selected a control group of normal mice. Bone marrow samples were collected in two groups. The nm23-M1 mRNA expression were detected by TaqMan quantitative real-time reverse transcription polymerase chain reaction(qRT-PCR) and analysis of its relationship with the occurrence and development of leukemia. Results The expression of nm23-M1 gene in bone marrow cells of mice with leukemia is 24 times of the normal control group. There was a significant difference between the two groups (P<0.05). Conclusion The nm23-M1 gene overexpressed .in mouse myelomonocytic leukemia, and had close relationship between and peripheral white blood cell count, the number of original cells in bone marrow and organ against the leukemia cases, regardless of the gender, age and leukemia in mice.

Key words: nm23-M1 gene, Myelomonocytic leukemia

CLC Number:

Q95-33

DONG Zheng,SUN Xue-dong,MAN Qiu-hong,et al. Expression of nm23-M1 Gene in Mouse Myelomonocytic Leukemia[J]. Laboratory Animal and Comparative Medicine, 2014, 34(1): 42-45. DOI: 10.3969/j.issn.1674-5817.2014.01.008.

References

[1] Steeg PS, Bevilacqua G, Kopper L, et al.Evidence for a novel gene associated with low tumor metastatic potential[J]. J Natl Cancer Inst, 1988,80(3):200-204.
[2] Chandrasekharappa SC, Gross LA, King SE, et al.The human NME2 gene lies within 18kb of NME1 in chrosome 17[J]. Gene Chromosomes Cancer, 1993, 6(4):245-248.
[3] Smagghe BJ, Stewart AK, Carter MG, et al.MUC1* Ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naive state[J]. PLoS One,2013,8(3):e58601.
[4] Okabe-Kado J, Kasukabe T, Kaneko Y.Extracellular NM23 protein as a therapeutic target for hematologic malignancies[J]. Adv Hematol, 2012:879368.
[5] Joosten M, Blazquez-Domingo M, Lindeboom F, et al.Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signaling[J]. J Biol Chem, 2004, 279(37):38169-38176.
[6] Okabe-Kado J, Kasukabe T, Honma Y.Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia[J]. Leuk Lymphoma, 1998, 32(1-2):19-28.
[7] An R, Meng J, Shi Q, et al.Expressions of nucleoside diphosphate kinase (nm23) in tumor tissues are related with metastasis and length of survival of patients with hepatocellular carcinoma[J]. Biomed Environ Sci, 2010, 23(4):267-272.
[8] Andolfo I, De Martino D, Liguori L, et al.Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue[J]. Naunyn Schmiedebergs Arch Pharmacol, 2011, 384(4-5):489-498.
[9] Liu C, Liu J, Wang X, et al.Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer[J]. J Surg Oncol, 2011, 104(2):181-186.
[10] Boissan M, De Wever O, Lizarraga F, et al.Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells[J]. Cancer Res, 2010, 70(19):7710-7722.
[11] Lilly AJ, Khanim FL, Hayden RE, et al.Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone[J]. Cancer Res, 2011, 71(3):1177-1186.
[12] Niitsu N, Nakamine H, Okamoto M.Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified[J]. Clin Cancer Res,2011, 17(9):2893-2899.
[13] Niitsu N, Tamaru J, Yoshino T, et al.A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy[J]. Ann Hematol,2011, 90(2):185-192.
[14] Yokoyama A, Okabe-Kado J, Wakimoto N, et al.Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies[J]. Blood, 1998, 91(6):1845-1851.

[1]	JIAO Qingzhen, WU Guihua, TANG Wen, FAN Fan, FENG Kai, YANG Chunxiang, QIAO Jian, DENG Sufang. Dynamic Monitoring and Analysis of Ammonia Concentration in Laboratory Animal Facilities Under Suspension of Heating Ventilation and Air Conditioning System [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 490-495.
[2]	LIU Wentao, LUO Yanhong, LONG Yongxia, LUO Qihui, CHEN Zhengli, LIU Lida. Common Environmental Problems and Testing Experiences in Laboratory Animal Facilities in Sichuan Province [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 483-489.
[3]	ZHAO Xin, WANG Chenxi, SHI Wenqing, LOU Yuefen. Advances in the Application of Zebrafish in the Research of Inflammatory Bowel Disease Mechanisms and Drug Development [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 422-431.
[4]	GONG Leilei, WANG Xiaoxia, FENG Xuewei, LI Xinlei, ZHAO Han, ZHANG Xueyan, FENG Xin. A Mouse Model and Mechanism Study of Premature Ovarian Insufficiency Induced by Different Concentrations of Cyclophosphamide [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 403-410.
[5]	LIN Zhenhua, CHU Xiangyu, WEI Zhenxi, DONG Chuanjun, ZHAO Zenglin, SUN Xiaoxia, LI Qingyu, ZHANG Qi. Evaluation of the Safety and Efficacy of Bone Cement in Experimental Pigs Using Vertebroplasty [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 466-472.
[6]	JIANG Juan, SONG Ning, LIAN Wenbo, SHAO Congcong, GU Wenwen, SHI Yan. Comparison of Histopathological and Molecular Pathological Phenotypes in Mouse Models of Intrauterine Adhesions Induced by Two Concentrations of Ethanol Perfusion [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 393-402.
[7]	LIU Yueqin, XUE Weiguo, WANG Shuyou, SHEN Yaohua, JIA Shuyong, WANG Guangjun, SONG Xiaojing. Observation of Digestive Tract Tissue Morphology in Mice Using Probe-Based Confocal Laser Endomicroscopy [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 457-465.
[8]	ZHENG Qingyong, YANG Donghua, MA Zhichao, ZHOU Ziyu, LU Yang, WANG Jingyu, XING Lina, KANG Yingying, DU Li, ZHAO Chunxiang, DI Baoshan, TIAN Jinhui. Recommendations for Standardized Reporting of Systematic Reviews and Meta-Analysis of Animal Experiments [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 496-507.
[9]	WANG Tingjun, LUO Hao, CHEN Qi. Discussion on AI-Based Digital Upgrade and Application Practice of Laboratory Animal Centers [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 473-482.
[10]	WANG Jiaoxiang, ZHANG Lu, CHEN Shuhan, JIAO Deling, ZHAO Heng, WEI Taiyun, GUO Jianxiong, XU Kaixiang, WEI Hongjiang. Construction and Functional Validation of GTKO/hCD55 Gene-Edited Xenotransplant Donor Pigs [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 379-392.
[11]	QIN Chao, LI Shuangxing, ZHAO Tingting, JIANG Chenchen, ZHAO Jing, YANG Yanwei, LIN Zhi, WANG Sanlong, WEN Hairuo. Study on the 90-day Feeding Experimental Background Data of SD Rats for Drug Safety Evaluation [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 439-448.
[12]	LIU Kun, LAN Qing, YI Bing, XIE Xiaojie. Key Challenges and Mitigation Strategies for Animal Pregnancy in Non-clinical Reproductive Toxicity Testing of Drugs [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 449-456.
[13]	. [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 508-514.
[14]	CHEN Ziyi, SUN Hongyan, KANG Pinfang, WU Wenjuan. Research Advances in Animal Experimental Models of Pulmonary Hypertension [J]. Laboratory Animal and Comparative Medicine, 2025, (): 1-12.
[15]	XU Yingtao, WANG Mengmeng, LIN Ping, CHI Haitao, WANG Yi, BAI Ying. Exosomes Improve Ischemic Stroke by Regulation of Ferroptosis Through the NRF2/SLC7A11/GPX4 Pathway in Mice [J]. Laboratory Animal and Comparative Medicine, 2025, (): 1-11.